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Bronchoalveolar lavage fluid neutrophilia is associated with the severity of pulmonary lesions 1 
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Background: The severe form of equine asthma is associated with pathological changes of the 29 
peripheral airways and pulmonary parenchyma that are only partly described. Also, the relationship 30 
between these structural alterations and the percentage of neutrophils found within the airway 31 
lumen, assessed by bronchoalveolar lavage fluid (BALF) cytology, remains ill-defined.  32 
Objective: To examine the histological lesions associated with equine asthma during disease 33 
exacerbation and remission, and their relationship with lung function and BALF neutrophilia.  34 
Study design: Observational retrospective study. 35 
Methods: Peripheral lung tissues, BALF cytology, and lung function data from 61 horses (22 36 
controls, 24 asthma exacerbations, and 15 asthma remission) were obtained from an equine 37 
pulmonary tissue bank. Two pathologists semi-quantitatively assessed histologic features, including 38 
airway wall inflammation, interstitial fibrosis, mucus cell hyperplasia, mucostasis, peribronchiolar 39 
metaplasia, presence of granuloma, and the overall severity of these lesions.  40 
Results: Mucostasis, mucus cell hyperplasia, peribronchiolar metaplasia, and interstitial fibrosis 41 
were associated with the disease exacerbation (p<0.05), and these changes were all  attenuated 42 
during remission. Airway wall inflammation was greater in horses with asthma in exacerbation 43 
compared to horses with asthma remission and control horses (p<0.05). Acute (neutrophilic) airway 44 
wall inflammation was more frequently detected in asthmatic cases compared to control horses 45 
(p<0.0001) and was associated with BALF neutrophilia >5% in control horses (p=0.002). The 46 
degree of bronchiolar inflammation was higher in asthmatic horses in remission stabled and treated 47 
pharmacologically compared to those kept on pasture (p=0.04).  48 
Main Limitations: Samples obtained from a  convenient cohort of horses was studied. 49 
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Conclusions: Severely asthmatic horses present parenchymal and peribronchial/peribronchiolar 50 
lesions possibly contributing to the obstructive nature of the disease.  51 
 52 
 53 
5113 words 54 




Severe equine asthma (also known as heaves or recurrent airway obstruction) is a chronic 57 
obstructive disease characterized by exaggerated contraction, inflammation, and structural 58 
alterations of the airways, when susceptible horses are stabled and fed hay. Antigen-induced 59 
inflammation of the airways is believed to be responsible for the development of the airway 60 
remodeling and associated airway obstruction [1]. The peripheral airways (those < 2mm in 61 
diameter) are the most important site of remodeling in severe equine asthma [2-4]. However, the 62 
inflammatory cell types present in these small asthmatic airways are not well described. Pulmonary 63 
inflammation in general is commonly assessed in the equine species by means of bronchoalveolar 64 
lavage fluid (BALF) cytology [5], which samples the lumens of lumens of intermediate and 65 
peripheral airways and the alveoli. There is little evidence supporting that BALF cytology correlates 66 
with interstitial or peripheral airway wall inflammation and remodeling in horses [2]. Severe equine 67 
asthma is characterized by marked BALF neutrophilia (>20-25%) during episodes of exacerbation, 68 
in association with increased lung resistance and elastance [6], and increased mucus production or 69 
secretion [7]. However, there is no correlation between BALF neutrophilia and lung function [8]. 70 
The relationship between BALF neutrophilia and peripheral airway wall pathology is ill-defined, 71 
mainly because of the inaccessibility of these airways preventing their assessment in clinical cases. 72 
To date, peripheral airway pathology can be evaluated only by means of pulmonary biopsy in living 73 
animals (restricted to research purposes), or at necropsy. Identifying a relationship between 74 
peripheral airway pathology and BALF cytology or lung function would allow a non-invasive 75 
estimation of the processes occurring in the peripheral airways and alveoli or interstitium of 76 
asthmatic and healthy horses. Furthermore, it may clarify the prognostic value of the degree of 77 
BALF neutrophilia in equine asthma.  78 
Peripheral airway remodeling is a hallmark of severe equine asthma. Early studies on peripheral 79 
lung biopsies obtained post-mortem or by thoracoscopy described the alterations occurring in the 80 
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submucosa of small peripheral airways [2; 9], and more recent reports have provided 81 
histomorphometric evidence showing that structural differences exist at this level. These studies 82 
have shown airway smooth muscle, collagen and elastic fiber deposition within the lamina propria 83 
in the asthmatic bronchioles when compared to the healthy ones [3; 4; 10]. These lesions are only 84 
partially reversible even when prolonged anti-asthma therapy is implemented [11]. Less is known 85 
about the histological alterations sustained by peribronchiolar tissues (connective tissue outside the 86 
smooth muscle layer), interstitium and alveolar walls of asthmatic horses and their possible 87 
reversibility. Moreover, their contribution to airflow obstruction remains ill-defined. 88 
In the present study, we performed a comprehensive histologic evaluation of remodeling and 89 
inflammation in peripheral lung tissues of severe asthmatic horses, including samples obtained 90 
during exacerbation and remission of the disease, and controls. A subgroup of control horses with 91 
>5% BALF neutrophilia but without clinical signs suggestive of lung disease was also studied. We 92 
sought to determine the histological lesions associated with equine asthma and whether they differ 93 
in horses experiencing exacerbation of the disease when compared to horses in remission of the 94 
disease. We studied histological lesions in horses where disease remission had been induced by 95 
antigen avoidance strategies or corticosteroids. Finally, the relationship between the histological 96 
lesions observed  and the BALF cytology and lung function were also studied.  97 
 98 
Materials and Methods 99 
Animals 100 
Lung tissues were obtained from an equine pulmonary tissue bank (http://btre.ca). Horses had been 101 
euthanized due to the severity of the disease or concurrent medical problems unrelated to the lungs. 102 
Horses included into the bank underwent lung function and BAL before euthanasia. However, for 103 
samples collected before 2005, BALF cytology data were not collected pre-mortem and only 104 
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historical values were available. Due to the difficulty to obtain pulmonary lung tissue from well-105 
characterized horses for research purposes we decided to include these subjects in our study. 106 
Inclusion criteria for each animal were the availability of a detailed history, pre-mortem lung 107 
function data (pulmonary resistance, RL, and pulmonary elastance, EL), historical or pre-mortem 108 
bronchoalveolar lavage fluid (BALF) cytology results, and at least 5 histological samples 109 
corresponding to the 5 regions of the lung identified in Fig 1. Controls were included if they have 1) 110 
no history of recurrent respiratory distress or systemic or respiratory disorders at the moment of 111 
euthanasia or in the past 6 months, 2) pre-mortem or a history of normal eosinophil (<1%) and mast 112 
cell (<2%) count at BALF cytology, and 3) a normal lung function (RL<1 cmH2O/L/s, and EL<1 113 
cmH2O/L) at pre-mortem examination. Horses with increased neutrophilia (>5%) at BALF 114 
cytology, but otherwise fulfilling the criteria outline above, were included as controls, in as it has 115 
previously shown that exposure to hay dust can induce temporary neutrophilia in otherwise healthy 116 
animals [10; 12]. Whether control horses had past episodes of respiratory disorders could not be 117 
ascertained in all cases (previous owners were unknown in some cases). Horses were classified as 118 
severe asthmatics if they had a documented history of 1) repeated and reversible episodes of labored 119 
breathing at rest in absence of signs of systemic illness, 2) altered lung function (RL≥1 cmH2O/L/s, 120 
and EL≥1 cmH2O/L) and 3) >5% neutrophils at BALF cytology. The status of clinical exacerbation 121 
vs. remission at the moment of euthanasia of severely asthmatic horses was defined based on the 122 
treatment history and lung function measured pre-mortem (1-7 days before, mean ± S.D.: 2±1 123 
days). Severe asthmatic horses in exacerbation had been stabled and fed hay for 4 weeks or more in 124 
absence of treatment and presented increased RL and EL. Horses in remission were either kept at 125 
pasture for >4 weeks or treated with corticosteroids alone or combined with bronchodilators before 126 
euthanasia for at least 2 weeks with normalization of RL and/or EL (at least one parameter within 127 
normal limits). Exclusion criteria for all horses were the administration of any antimicrobial or 128 
antinflammatory drug during the week preceding the euthanasia (except for inhaled/oral 129 





Lung samples were fixed in 10% neutral-buffered formalin for 48-72 hours before paraffin 133 
embedding. Five μm sections were cut and stained with HEPS (hematoxylin-eosin-phloxine-134 
saffron). Experienced veterinary (PH) and human thoracic pathologists (PJ) assessed the following 135 
parameters independently: lesion distribution patterns (bronchiolocentric, subpleural, paraseptal, or 136 
diffuse), overall severity (0: absent; 1: mild; 2: moderate; 3: severe), eosinophilia (0: no cell; 1: rare 137 
cells; 2: few cells; 3: multiple cells), presence of granuloma (present/absent), mucostasis 138 
(present/absent), mucus cell hyperplasia (present/absent), peribronchiolar metaplasia 139 
(present/absent), interstitial fibrosis (present/absent), and distribution of interstitial fibrosis 140 
(bronchiolocentric, diffuse, mixed). Type and severity of bronchial and bronchiolar inflammation 141 
were also assessed. The type of inflammation was assessed as: acute, when inflammation was 142 
overwhelmingly neutrophilic (and luminal); chronic, when inflammation was overwhelmingly 143 
lymphoplasmacytic (and parietal); and mixed, when both types were significantly present. 144 
Inflammation was graded using a semi-quantitative scoring system that was based on the subjective 145 
assessment of the average degree of leukocytic infiltration and the proportion of affected airways. 146 
All slides were read a first time to assess the range of inflammation intensity and establish the 147 
number of score categories, and then a second time to grade each case. For individual cases, 148 
inflammation was graded as: 0 = absent; 1 = mild, when only a few scattered leukocytes were 149 
present multifocally in the wall (lymphocytes and plasma cells) and/or the lumen (neutrophils); 2 = 150 
moderate, when a few to several lymphocytes and plasma cells were present circumferentially in the 151 
wall and/or neutrophils formed conspicuous aggregates in the lumen; and 3 = severe when 152 
numerous lymphocytes and plasma cells were present circumferentially in the wall and/or 153 
neutrophils variably filled the lumen. Then, slides from half the cases were randomly selected and 154 
re-evaluated to insure repeatability. All 5 sections of the same horse were analyzed together (i.e. the 155 
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pathologists knew these samples belonged to the same horse). Both pathologists were blinded to the 156 
clinical diagnosis of the horses.  157 
 158 
Data analysis 159 
Statistical analysis was performed using Prism 6 software (GraphPad Inc., La Jolla, CA, USA) and 160 
GraphPad QuickCalcs (https://graphpad.com/quickcalcs/kappa1/). Inter-observer agreement was 161 
evaluated using Kappa Cohen’s test.  The results of the pathologist with more experience in the 162 
assessment of veterinary samples (PH) were used for subsequent analysis. One-way ANOVA and 163 
Tukey’s post-tests were used for comparing continuous variables (age, lung function parameters, 164 
BAL neutrophilia) between the 3 groups. The mean values of ordinal variables (overall severity, 165 
eosinophilia, bronchial and bronchiolar inflammation, severity of interstitial fibrosis) in the 3 166 
groups were compared with Kruskal-Wallis tests with Dunn’s post-tests. Chi squared tests were 167 
used for comparing the distribution, expressed as percentages of nominal (type of 168 
bronchial/bronchiolar inflammation) or binomial variables (mucostasis, 169 
peribronchial/peribronchiolar metaplasia, mucous cell hyperplasia, interstitial fibrosis, granulomas). 170 
Mann-Whitney U-test was used for comparing control horses with BALF neutrophilia ≥ or <5% 171 
and the treatments to induce disease remission (antigen avoidance vs. pharmacological treatment). 172 
Student's t-test was employed to evaluate whether severity of peripheral lung lesions (overall 173 
severity ≤1 vs. >1) or the type of peripheral lung inflammatory infiltrate (chronic vs. mixed) 174 
significantly affected lung function and BALF cytology. BALF cytology results were correlated 175 
using the Spearman or Pearson test with Bonferroni correction for multiple comparisons for each 176 
group of horses, depending on data distribution. Horses lacking pre-mortem BALF neutrophil 177 






Lung tissues from 61 horses were studied; 22 were classified as controls, 15 as horses with severe 182 
asthma in clinical remission, and 24 as horses with severe asthma in exacerbation of the disease. 183 
Clinical details of the horses are described in Table 1. Pre-mortem BALF neutrophilia data were 184 
not available for 3 control horses and for 5 asthmatic horses in exacerbation, for which historical 185 
data were used to confirm the diagnosis of asthma. There was no significant difference in age, 186 
weight, or sex distribution among groups (p>0.05). As expected, horses with asthma in exacerbation 187 
had significantly increased RL, EL, and BALF neutrophilia compared to the controls (p<0.001) and 188 
to horses with asthma in remission (p<0.001 for RL and EL, and p<0.05 for BALF neutrophilia).  189 
 190 
Agreement 191 
The agreement between the 2 pathologists was fair to optimal for all the histological parameters 192 
evaluated (Supplementary item 1).  193 
 194 
Distal lung lesions 195 
Bronchocentric/bronchiolocentric lesions were observed in 28/29 asthmatic horses (1 horse had 196 
diffuse lesions). When lesions were present in control horses, they were also classified as 197 
bronchiolocentric (14/22 cases). The overall severity of the pathological processes identified within 198 
peripheral lung tissue was greater in asthmatic horses in exacerbation compared to those in 199 
remission (p<0.05) and control horses (p<0.001). Mucostasis, mucus cell hyperplasia, 200 
peribronchiolar metaplasia, and interstitial fibrosis were observed more frequently in asthmatic 201 
horses whether in exacerbation or in remission, when compared to control horses (Table 2). Also, 202 
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an increased number of asthmatic horses in exacerbation presented mucostasis, mucus cell 203 
hyperplasia, peribronchial/peribronchiolar metaplasia, and interstitial fibrosis compared to 204 
asthmatic horses in remission of the disease (Table 2). Discrete granulomas were occasionally 205 
observed both in asthmatic and in control horses; no micro-organisms were detected with Gram, 206 
Gomori's methenamine silver and Ziehl-Neelsen stains.  207 
The severity of bronchial inflammation was greater in asthma exacerbation compared to control 208 
animals (p<0.001)(Fig 3A). The type of bronchial inflammation was, however, differently 209 
distributed between asthmatic horses in remission and control animals (p=0.0003). Specifically, foci 210 
of acute bronchitis were more frequently detected in asthmatic horses compared to controls, where 211 
the inflammatory response was either chronic or mixed (Fig 3B). The severity of bronchiolar 212 
inflammation was greater during asthma exacerbation compared to that observed in control horses 213 
(p<0.001) and in asthmatic horses during disease remission (p<0.05, Fig 3C).  No differences were 214 
observed between the degree of bronchiolar inflammation detected in asthmatic horses in remission 215 
and controls. While most horses presented a mild to moderate chronic inflammation of the 216 
bronchioles in all groups studied, the proportion of horses with acute bronchiolar inflammation was 217 
greater in horses with asthma, both in remission and in exacerbation, compared to controls 218 
(p<0.0001), and in horses with asthma in exacerbation compared to those in remission of the 219 
disease (p=0.0008, Fig 3D). Eosinophilic infiltration of the peripheral lung was lower in horses with 220 
asthma during disease exacerbations compared to control horses (p<0.001), while horses with 221 
asthma in remission presented variable degrees of pulmonary eosinophilia (Table 2).  222 
 223 
Effect of the treatment strategy employed for inducing remission 224 
Asthma remission was induced by means of antigen avoidance (alone) in 6/15 horses and by 225 
pharmacological treatment (oral corticosteroids, inhaled corticosteroids, or inhaled combinations of 226 
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corticosteroids and long-acting β2-agonists) in 7 stabled horses. The management of the 2 remaining 227 
horses was undetermined and they were excluded from the statistical analysis investigating the 228 
effects of the treatment strategy employed for inducing remission. The degree of bronchiolar 229 
inflammation was higher in horses stabled and treated pharmacologically compared to those kept on 230 
pasture (p=0.04, Table 3). Although BALF neutrophilia was higher in horses treated 231 
pharmacologically while stabled compared to horses kept at pasture (mean±S.D.: 10.75%±10.28% 232 
and 23.5%±16.72%, respectively), the difference was not statistically significant (p=0.07, unpaired 233 
one-way t-test, post-hoc calculation of study power=36.8%) as there were two horses at pasture for 234 
1 month with values of BALF neutrophilia still >20%. No difference was observed between the 2 235 
groups in terms of overall disease severity, pulmonary eosinophilia, bronchial inflammation, 236 
mucostasis, peribronchial/peribronchiolar metaplasia, mucus cell hyperplasia, or interstitial fibrosis.  237 
 238 
Relationship between BALF inflammation, lung function, and peripheral lung lesions 239 
Asthmatic horses in exacerbation with moderate to severe pulmonary lesions (overall severity >1) 240 
had a lower BALF neutrophil percentage (p=0.006, Fig 4A) but similar values of RL (p=0.32) and 241 
EL (p=0.95) compared to those with mild pulmonary lesions (overall severity ≤1). Of these horses, 242 
21 out of 24 presented a mixed pulmonary inflammation, which prevented the statistical analysis of 243 
the effect of inflammation type on clinical outcomes. BALF neutrophilia was significantly lower in 244 
the presence of peripheral mucostasis in this group of horses (p=0.001, Fig 4B).  245 
Horses with asthma in remission with chronic infiltrates had similar percentages of neutrophil in 246 
their BALF (p=0.19), and similar values of RL (p=0.93) and EL (p=0.28) than those with a mixed 247 
airway inflammatory pattern.  248 
Control horses with chronic, mixed, or no evidence of bronchiolar inflammation had similar lung 249 
function values (lung resistance, p=0.80; lung elastance, p=0.53). However, they differed for the 250 
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percentage of neutrophils in their BALF (p=0.0003, Fig 4C). Specifically, control horses with a 251 
mixed inflammatory infiltrate in their distal airways (n=6) had a higher percentage of BALF 252 
neutrophils (mean±SD: 16.3±5.7, all had BALF neutrophils >5%) compared to those with evidence 253 
of chronic or no inflammation at histology. Control horses with >5% neutrophils in their BALF had 254 
a significantly greater degree of bronchial and bronchiolar inflammation (p=0.0003 and p=0.002, 255 
respectively) and a greater overall severity of pulmonary lesions (p=0.0004) compared to control 256 
horses with <5% neutrophils in their BALF. No differences were detected between control horses 257 
with less or more than 5% neutrophils in BALF for the parameters eosinophilia (p=0.5), interstitial 258 
fibrosis (p=0.4), mucus cell hyperplasia (p=0.2), peribronchial metaplasia (p=0.1), and mucostasis 259 
(p=0.05). Raw data are available online in Supplementary item 2 and 3. In control horses, BALF 260 
neutrophilia correlated significantly with the severity of bronchial and bronchiolar inflammation 261 
(r=0.70, p=0.0008, and r=0.50, p=0.03, respectively) and with overall lesion severity (r=0.62, 262 
p=0.004).  263 
Results of the relationship between peripheral lung lesions, BALF neutrophilia, and lung function in 264 
each group studied are reported in Supplementary items 4 and 5. 265 
 266 
Discussion 267 
This study provides the first evidence that alterations of the peripheral peribronchial/peribronchiolar 268 
tissues and interstitium occur in the distal lung of asthmatic horses with a higher prevalence 269 
compared to age-matched controls. These changes may contribute to the development of airflow 270 
obstruction, and their presence may explain the lack of a significant correlation between bronchial 271 
remodeling and pulmonary resistance or elastance measured during disease exacerbation [4]. Our 272 
results also suggest that asthmatic horses with BALF neutrophilia >20% during disease 273 
exacerbation are less likely to have severe peripheral pulmonary lesions compared to asthmatic 274 
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horses with <20% neutrophils in their BALF (for which we propose the term "paucigranulocytic 275 
asthmatic horses"). Mucus plugs preventing saline withdrawal from the most distal airways could 276 
explain this finding. Increased percentages of neutrophils in BALF of clinically healthy horses were 277 
not associated with bronchial or parenchymal remodeling. However, they were associated with an 278 
acute inflammatory process of the terminal airways.  279 
Severe equine asthma is characterized by airway remodeling and inflammation [13]. Previous 280 
studies limited to lung tissues from asthmatic horses have described the more severe lesions as 281 
being located at the distal level of the bronchial tree [2; 14; 15]. The semi-quantitative assessment 282 
of peripheral lung tissue inflammation revealed similar degrees of cellular infiltrate in pulmonary 283 
biopsy samples harvested from asthmatic horses and controls [16]. To our knowledge, no study has 284 
systematically investigated whether any difference exists in peripheral airway wall inflammation of 285 
asthmatic and healthy horses. Using a semi-quantitative and blinded approach, our results confirm 286 
that distal airway inflammation is a feature of severe equine asthma and that these changes are more 287 
pronounced in the smallest airways. Even among distal airways, the bronchioles (lacking cartilage) 288 
sustain more severe inflammatory insults compared to the bronchi. Indeed, 88% of the horses with 289 
asthma in exacerbation had acute bronchiolitis graded on average 1.6 out of 2, while acute 290 
bronchitis was detected in only 67% of them and graded on average 1 out of 2. Only 27% and 18% 291 
of control horses had acute inflammation in their bronchioles and bronchi, respectively, with a mean 292 
severity grade of 0.8 and 0.25. The milder degree of inflammation observed in peripheral bronchi 293 
compared with adjacent bronchioles appears to be without clinical significance, as it is also 294 
observed in healthy animals. The reasons of this finding are not obvious. It is possible that the size 295 
of the inhaled antigens responsible for the development of equine asthma could favor their 296 
deposition in the most peripheral airways of the lung. For example, the spores of the fungus 297 
Aspergillus fumigatus, which has been implicated in equine asthma pathogenesis [17-19], have an 298 
average size of 2-3.5 μm [20], which allows their deposition in the most distal airways and alveoli. 299 
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Also, the non-ciliated epithelium of the most distal bronchioles could reduce the clearance of 300 
external particles that deposit at this level during normal breathing, inducing more severe reactions 301 
at this site.  302 
Histological evaluation of the distal airways in vivo is limited by their inaccessibility, which 303 
prevents the direct assessment of pathological processes occurring at this level [21]. Distal lung 304 
sampling is achieved by thoracoscopy or transcutaneously [22; 23]; however, due to the 305 
invasiveness of the procedures and related risks, it is done mainly for research purposes. For this 306 
reason, BAL is commonly performed as a diagnostic procedure in horses suspected to have severe 307 
asthma, with the presence of moderate to severe neutrophilia at BALF cytology (>20-25%) as the 308 
only parameter considered for confirming the diagnosis, and thus the presence of peripheral airway 309 
pathology [1]. Nevertheless, there is little evidence supporting BALF neutrophilia as a specific 310 
marker of the severity of peripheral airway inflammatory disease [15]. Our results suggest that the 311 
significance of neutrophilic luminal inflammation varies depending on the clinical condition of the 312 
horse. Horses classified as controls in our study and presenting increased percentages of neutrophils 313 
at BALF cytology (>5%) had histologic evidence of acute neutrophilic inflammation in their distal 314 
airways. Of note, having more than 5% of neutrophils in BALF is considered diagnostic for mild 315 
neutrophilic equine asthma (or neutrophilic IAD, Inflammatory Airway Disease) when associated 316 
with compatible clinical signs [1]. In the present study, as there was no history of lung diseases, 317 
these horses were not treated as a separate group. In this perspective, our observations provide the 318 
first histologic evidence that BALF neutrophilic inflammation (>5% neutrophils) is associated with 319 
acute distal airway inflammation, even in absence of overt clinical signs suggestive of lung 320 
diseases. On the other hand, during disease exacerbation, horses with mild pulmonary lesions had 321 
higher neutrophil percentages in their BALF cytology compared to horses in exacerbation with 322 
severe histologic lesions in their distal lung. Horses with neutrophilia <20%, all had an overall 323 
severity score >1, compared to horses with BALF neutrophilia >20% that presented an overall 324 
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severity score >1 only in 4/12 cases (33%). As BALF neutrophilia >20% is considered the threshold 325 
for the diagnosis of severe asthma based on previous studies [1], we propose the term 326 
paucigranulocytic asthma for those severely asthmatic horses presenting with <20% neutrophilia in 327 
BALF cytology during disease exacerbations. Of note, all paucigranulocytic cases (7/24, 29% of the 328 
group) had pulmonary lesions with an overall severity score ≤1 (mild lesions), suggesting that the 329 
number of inflammatory cells is low also within the airway walls and interstitium. The significant 330 
association found between BALF neutrophilia <20% and the presence of peripheral mucostasis 331 
during episodes of severe equine asthma exacerbations could explain our results as mucus plugs 332 
within the peripheral airways may prevent the wash solution reaching the alveoli and terminal non-333 
respiratory bronchioles to be recovered.  334 
Submucosal remodeling occurs in the peripheral airways of asthmatic horses [4; 10]. There is less 335 
information concerning peribronchial/peribronchiolar tissues and interstitium, which are commonly 336 
overlooked. The presence of chronic bronchoalveolar inflammation suggests that not only the 337 
airways but also the alveolar walls may undergo remodeling processes in severe equine asthma. Our 338 
findings show that peribronchiolar metaplasia and interstitial bronchiolocentric fibrosis are 339 
overrepresented in asthmatic horses compared to healthy animals. The prevalence of these lesions is 340 
lower in asthmatic horses during disease remission. While the clinical implication and the 341 
mechanisms driving peribronchiolar metaplasia are still ill-defined [24], fibrosis is commonly 342 
associated with chronic damage and reparation processes, with increased concentration of TGF-β in 343 
lung tissues, and with a Th-2-biased inflammatory response [25]. Th-2 shifted inflammatory 344 
response has previously been demonstrated in BALF obtained from horses with asthma [26], while 345 
to our knowledge no studies have investigated TGF-β expression in equine peripheral lung tissues. 346 
However, TGF-β levels are similar in BALF, BAL cells, and in endobronchial biopsies of healthy 347 
and severe asthmatic horses [27; 28], and unaffected by treatment [11]. Th-2 type cytokines are also 348 
considered important mediators of mucus cell hyperplasia [29; 30]. In our study, mucostasis and 349 
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mucus cell hyperplasia followed the same lesion distribution described for interstitial fibrosis 350 
among the groups studied.  351 
In conclusion, severe asthmatic horses present alterations of the peripheral 352 
peribronchial/peribronchiolar tissues and interstitium in addition to those already described for the 353 
submucosal tissues of peripheral airway walls, which possibly contribute to the obstructive nature 354 
of the disease. These changes are mild in asthmatic horses in remission of the disease suggesting 355 
they might be, at least partly, reversible. Nevertheless, they remain of a greater magnitude in 356 
asthmatic horses in remission of the disease compared to control horses, independently of the 357 
treatment strategy adopted to induce disease remission. BALF neutrophilia >5% is associated with 358 
acute bronchiolitis in control horses. Contrarily, mild pulmonary lesions and the absence of 359 
peripheral mucostasis are associated with a greater (>20%) BALF neutrophilia during equine 360 
asthma exacerbations. 361 
 362 
  363 
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List of abbreviations 364 
ASM: airway smooth muscle; BAL: bronchoalveolar lavage; BALF bronchoalveolar lavage fluid; 365 
EL: pulmonary elastance; HEPS: hematoxylin-eosin-phloxine-saffron; RL: pulmonary resistance; 366 
TGF-β: tumor growth factor β; Th: T helper.  367 
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Table 1. Details of the horses studied. 497 
 Controls Asthma remission Asthma exacerbation 
N 22 15 24 
Age [years] 20.4±5.6 22.4±5.9 23.2±6.2 
Sex (F/M) 18/4 9/5 18/6 
RL [cm H2O/L/s] 0.552±0.223 0.684±0.327 2.522±1.049*
,†
 
EL [cm H2O/L] 0.521±0.237 0.649±0.336 4.921±4.547*
,†
 
BAL neutrophil % 6.3±7.7 16.2±14.6 34.6±26.6*
,‡
 
Data are presented as mean ± S.D. One-way ANOVA with Tukey post-tests was used for statistical 498 
analysis. *: different from controls (p<0.0001). 
†
: different from asthma remission (p<0.0001). 
‡
: 499 
different from asthma remission (p<0.05). RL: pulmonary resistance; EL: pulmonary elastance; 500 















Table 2. Prevalence and severity of peripheral lung lesions.  514 









Overall severity [range: 0-3] 0.5 (0; 1) 0.5 (0.5; 1) 1.5 (1; 1.5)
†,‡
 
Eosinophilia [range: 0-3] 0.75 (0.5; 2) 0.5 (0; 1) 0 (0; 0.5)
‡
 
     




















Granulomatous lesions* 1/22 (4)  2/15 (13) 1/24 (4) 
Overall severity and eosinophilia are expressed as median (interquartile range) * Results are 515 
presented as the number of cases in which the lesion was present/total number of cases 516 
(percentage). †: different from asthma remission. ‡: different from control. 517 
 518 
 519 
Table 3. Effect of the strategy employed to induce disease remission on peripheral lung lesions.  520 
 Horses with asthma in remission 









Overall severity [range: 0-3] 0.5 (0.375; 1) 0.5 (0.5; 1) 
Eosinophilia [range: 0-3] 0.5 (0; 1.875) 0.5 (0.5; 1) 
Bronchial inflammation [range: 0-3] 0.25 (0; 0.625) 0.5 (0.5; 0.5) 
Bronchiolar inflammation [range: 0-3] 0.75 (0.5; 1) 1 (1; 1)
†
 
    
Mucostasis* 1/6 (17) 1/7 (14) 
Mucus cell hyperplasia* 3/6 (50) 2/7 (28) 
Peribronchial/peribronchiolar metaplasia* 2/6 (33) 2/7 (28) 
Interstitial fibrosis* 2/6 (33) 3/7 (43) 
Granuloma* 0/6 (0) 2/7 (28) 
Overall severity, eosinophilia, and airway inflammation are expressed as median (interquartile 521 
range). * Results presented as the number of cases in which the lesion was present/total number of 522 

















Figure 1. Anatomical sites sampled at necropsy for the assessment of distal lung histology. One 538 
randomly chosen lung per horse was assessed. A biopsy of 6-8 cm
3
 in size was harvested at each 539 
anatomical site (A, B, C, D, and E) within 2 hours post-mortem and processed for histology. 540 




Figure 2. Histological lesions observed in asthmatic horses. A) Interstitial fibrosis (asterisks), 2.5x. 543 
B) Mucus cell hyperplasia (arrowheads), 10x. C) Peribronchial metaplasia (arrows), 10x. D) 544 
Mucostasis (stars), 10x. HEPS staining. Scale bar: 400 µm in panel A; 100 µm in panels B, C, and 545 
D. 546 




Figure 3. Peripheral airway inflammatory infiltrate. Severity of bronchial (A) and bronchiolar (B) 549 
inflammation in the three groups of horses studied is reported in the left panels, while inflammation 550 
type is shown in the right panels.  551 




Figure 4. Determinants of BALF neutrophilia in asthmatic and control horses. Effect of the 554 
histological severity of pulmonary lesions (A) and of the presence of peripheral mucostasis (B) on 555 
BALF neutrophil percentage in horses with asthma in exacerbation of the disease. Effect of the type 556 
of bronchiolar inflammatory infiltrate on BALF neutrophil percentage in control horses (C). The 557 
dashed line identifies 5% of neutrophils in BALF, currently considered as the cutoff for the 558 
diagnosis of equine asthma.   559 
 560 
